During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza vaccine effectiveness (IVE) against any influenza type to be 70% (95% confidence interval (CI): 51 to 81%) for primary care patients with acute respiratory illness (ARI) and 77% (95% CI: 21 to 93%) for hospitalised patients with severe ARI. In primary care, where most subtyped viruses (61%; 145/237) were A(H1N1), adjusted IVE was 77% (95% CI: 56 to 88%) against A(H1N1)pdm09.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451132PMC
http://dx.doi.org/10.2807/1560-7917.ES.2024.29.40.2400618DOI Listing

Publication Analysis

Top Keywords

primary care
12
children aged
8
test-negative case-control
8
effectiveness influenza
4
influenza vaccines
4
vaccines children
4
aged 59 months
4
59 months test-negative
4
case-control study
4
study primary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!